| Symbol | MANE |
|---|---|
| Name | VERADERMICS, INC |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 470 JAMES STREET, NEW HAVEN, CT 06513 |
| Telephone | 228.372.3376 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NYSE;NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001827635 |
| Description | None |
New Form D - Veradermics, Inc <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001827635-26-000020 <b>Size:</b> 19 KB
Read moreVeradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium
Read moreVeradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Read moreNew Form SCHEDULE 13G - Veradermics, Inc <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057224 <b>Size:</b> 27 KB
Read moreSUVRETTA CAPITAL MANAGEMENT, LLC 🟢 acquired 300.0K shares (2 derivative) of Veradermics, Inc (MANE) Transaction Date: May 01, 2026 | Filing ID: 000415
Read moreNew Form SCHEDULE 13D/A - Veradermics, Inc <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0000899140-26-000416 <b>Size:</b> 16 KB
Read moreNew Form SCHEDULE 13D/A - Veradermics, Inc <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-207186 <b>Size:</b> 23 KB
Read moreNew Form SCHEDULE 13D - Veradermics, Inc <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001013594-26-000528 <b>Size:</b> 29 KB
Read moreNew Form 3 - Veradermics, Inc <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001013594-26-000527 <b>Size:</b> 5 KB
Read more